Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019

Wigerblad, 2022, Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases, Nat Rev Immunol, 1 Cao, 2019, P2X7 receptor: a potential therapeutic target for autoimmune diseases, Autoimmun Rev, 18, 767, 10.1016/j.autrev.2019.06.009 American Autoimmune Related Disease Association Scherlinger, 2020, Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014, Autoimmun Rev, 19, 10.1016/j.autrev.2020.102531 Goswami, 2022, Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: a systematic review and meta-analysis, Autoimmun Rev, 21, 10.1016/j.autrev.2021.102997 Zhao, 2022, Stem cell educator therapy in type 1 diabetes: from the bench to clinical trials, Autoimmun Rev, 21, 10.1016/j.autrev.2022.103058 Felten, 2019, The pipeline of targeted therapies under clinical development for primary Sjögren’s syndrome: a systematic review of trials, Autoimmun Rev, 18, 576, 10.1016/j.autrev.2018.12.008 Sebbag, 2019, The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization burden of diseases database, Ann Rheum Dis, 78, 844, 10.1136/annrheumdis-2019-215142 Cao, 2023, Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019, Autoimmun Rev, 22, 10.1016/j.autrev.2023.103326 Kwon, 2023, Higher genetic risk loads confer more diverse manifestations and higher risk of lupus nephritis in systemic lupus erythematosus, Arthritis Rheumatol, 10.1002/art.42516 Chen, 2022, The effect of air pollution exposure on risk of outpatient visits for Sjogren’s syndrome: a time-series study, Environ Res, 214 Arnaud, 2014, Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study, Autoimmun Rev, 13, 1082, 10.1016/j.autrev.2014.08.034 Barrio-Cortes, 2023, Prevalence and comorbidities of Sjogren’s syndrome patients in the Community of Madrid: a population-based cross-sectional study, Joint Bone Spine, 90, 10.1016/j.jbspin.2023.105544 Kang, 2023, Prevalence and incidence of vitiligo and associated comorbidities: a Nationwide population-based study in Korea, Clin Exp Dermatol, 10.1093/ced/llad028 Institute of Health Metrics and Evaluation. Global Burden of Disease Study 2019 (GBD 2019) data resources. Available from: https://ghdx.healthdata.org/gbd-2019. Paik, 2022, Global burden of NAFLD and chronic liver disease among adolescents and young adults, Hepatology., 75, 1204, 10.1002/hep.32228 2020, Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019, Lancet., 396, 1204, 10.1016/S0140-6736(20)30925-9 2020, Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019, Lancet., 396, 1223, 10.1016/S0140-6736(20)30752-2 Joinpoint Trend Analysis Software, Version 4.9.1.0-April 2022; Surveillance research program, Division of Cancer Control & Population Sciences, National Cancer Institute. Available from: https://surveillance.cancer.gov/joinpoint/. Clegg, 2009, Estimating average annual per cent change in trend analysis, Stat Med, 28, 3670, 10.1002/sim.3733 Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med., 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z Ramos, 2015, Genetics of autoimmune diseases: insights from population genetics, J Hum Genet, 60, 657, 10.1038/jhg.2015.94 Zhao, 2019, Emerging role of air pollution in autoimmune diseases, Autoimmun Rev, 18, 607, 10.1016/j.autrev.2018.12.010 Miller, 2023, The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention, Curr Opin Immunol, 80 Vojdani, 2014, A potential link between environmental triggers and autoimmunity, Autoimmune Dis, 2014